BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12704643)

  • 1. Synchronized prostate cancer cells for studying androgen regulated events in cell cycle progression from G1 into S phase.
    Cifuentes E; Croxen R; Menon M; Barrack ER; Reddy GP
    J Cell Physiol; 2003 Jun; 195(3):337-45. PubMed ID: 12704643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis.
    Kuwajerwala N; Cifuentes E; Gautam S; Menon M; Barrack ER; Reddy GP
    Cancer Res; 2002 May; 62(9):2488-92. PubMed ID: 11980638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
    Fribourg AF; Knudsen KE; Strobeck MW; Lindhorst CM; Knudsen ES
    Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J
    Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM; Hay N; Liao S
    Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor regulates Cdc6 in synchronized LNCaP cells progressing from G1 to S phase.
    Bai VU; Cifuentes E; Menon M; Barrack ER; Reddy GP
    J Cell Physiol; 2005 Aug; 204(2):381-7. PubMed ID: 15887248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation of G1-S-phase cyclin-dependent kinase 2/cyclin complexes occurs during the acquisition of a polyploid DNA content.
    Datta NS; Williams JL; Long MW
    Cell Growth Differ; 1998 Aug; 9(8):639-50. PubMed ID: 9716181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
    Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of cell cycle related gene expression in cultured immortalized human lens epithelial cell].
    Wu M; Li S; Zeng J; Gao J; Liu Y
    Zhonghua Yan Ke Za Zhi; 2002 Jun; 38(6):367-71. PubMed ID: 12139816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
    Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
    Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21(CIP1) levels in androgen-independent human prostate cancer cells.
    Knight-Krajewski S; Welsh CF; Liu Y; Lyons LS; Faysal JM; Yang ES; Burnstein KL
    Oncogene; 2004 Jul; 23(32):5513-22. PubMed ID: 15077174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
    Zi X; Grasso AW; Kung HJ; Agarwal R
    Cancer Res; 1998 May; 58(9):1920-9. PubMed ID: 9581834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.
    Gregory CW; Johnson RT; Presnell SC; Mohler JL; French FS
    J Androl; 2001; 22(4):537-48. PubMed ID: 11451350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
    Damiens E; El Yazidi I; Mazurier J; Duthille I; Spik G; Boilly-Marer Y
    J Cell Biochem; 1999 Sep; 74(3):486-98. PubMed ID: 10412049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27.
    Park WH; Seol JG; Kim ES; Jung CW; Lee CC; Binderup L; Koeffler HP; Kim BK; Lee YY
    Exp Cell Res; 2000 Feb; 254(2):279-86. PubMed ID: 10640426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
    Bilodeau JF; Faure R; Piedboeuf B; Mirault ME
    Exp Cell Res; 2000 May; 256(2):347-57. PubMed ID: 10772807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes.
    Lu S; Tsai SY; Tsai MJ
    Cancer Res; 1997 Oct; 57(20):4511-6. PubMed ID: 9377562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells.
    Hobeika AC; Subramaniam PS; Johnson HM
    Oncogene; 1997 Mar; 14(10):1165-70. PubMed ID: 9121765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells.
    Miyazaki H; Watabe T; Kitamura T; Miyazono K
    Oncogene; 2004 Dec; 23(58):9326-35. PubMed ID: 15531927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.